Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Deborah Doroshow, MD, PhD is Assistant Professor of Medicine at the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai. She divides her clinical practice and research between the Center for Thoracic Oncology, where she sees patients with lung cancer, and the Early Phase Trials Unit, where she sees patients with a variety of solid tumors on phase 1 and 2 trials of novel agents and leads efforts in targeted therapy development. Her research, which is funded by an ASCO Career Development Award, focuses on use of novel agents to target DNA damage and repair processes and aberrant cell signaling as well as the outcomes and experiences of participants on early phase clinical trials.
Session 11: Fusions as a Target in Lung Cancer: RET, NTRK, NRG1, ROS1
Friday, September 22, 2023
11:00 AM – 11:45 AM ET